BUSINESS COMBINATIONS (Details 2)	12 Months Ended			0 Months Ended	6 Months Ended	12 Months Ended				12 Months Ended				12 Months Ended				12 Months Ended				12 Months Ended				12 Months Ended				12 Months Ended				12 Months Ended			12 Months Ended												0 Months Ended		12 Months Ended				12 Months Ended
	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Jun. 18, 2012 OraPharma USD ($)	Dec. 31, 2012 OraPharma USD ($)	Dec. 31, 2012 OraPharma USD ($)	Jun. 18, 2012 OraPharma Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 OraPharma Measurement Period Adjustments USD ($)	Dec. 31, 2012 OraPharma Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 OraPharma Product brands	Jun. 18, 2012 OraPharma Product brands Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 OraPharma Product brands Measurement Period Adjustments USD ($)	Dec. 31, 2012 OraPharma Product brands Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 OraPharma Corporate brands	Jun. 18, 2012 OraPharma Corporate brands Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 OraPharma Corporate brands Measurement Period Adjustments USD ($)	Dec. 31, 2012 OraPharma Corporate brands Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations USD ($)	Dec. 31, 2012 Other Business Combinations Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Measurement Period Adjustments USD ($)	Dec. 31, 2012 Other Business Combinations Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations Product brands	Dec. 31, 2012 Other Business Combinations Product brands Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Product brands Measurement Period Adjustments USD ($)	Dec. 31, 2012 Other Business Combinations Product brands Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations Corporate brands	Dec. 31, 2012 Other Business Combinations Corporate brands Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Corporate brands Measurement Period Adjustments USD ($)	Dec. 31, 2012 Other Business Combinations Corporate brands Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations Product rights	Dec. 31, 2012 Other Business Combinations Product rights Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Product rights Measurement Period Adjustments USD ($)	Dec. 31, 2012 Other Business Combinations Product rights Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations Royalty agreement	Dec. 31, 2012 Other Business Combinations Royalty agreement Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Royalty agreement Amounts Recognized (as adjusted) USD ($)	Dec. 31, 2012 Other Business Combinations Partner relationships	Dec. 31, 2012 Other Business Combinations Partner relationships Amounts Recognized as of Acquisition Date (as previously reported) USD ($)	Dec. 31, 2012 Other Business Combinations Partner relationships Amounts Recognized (as adjusted) USD ($)	Oct. 02, 2012 Johnson & Johnson Consumer Companies Inc USD ($)	Sep. 28, 2012 Johnson & Johnson North America USD ($)	Sep. 24, 2012 QLT Inc. and QLT Ophthalmics, Inc. USD ($)	Sep. 24, 2012 QLT Inc. and QLT Ophthalmics, Inc. Outside the U.S. USD ($)	Sep. 24, 2012 QLT Inc. and QLT Ophthalmics, Inc. U.S USD ($)	May 23, 2012 University Medical Pharmaceuticals USD ($)	Dec. 31, 2012 Atlantis USD ($)	May 02, 2012 Atlantis USD ($)	May 02, 2012 Atlantis MXN	Mar. 13, 2012 Gerot Lannach USD ($)	Mar. 13, 2012 Gerot Lannach EUR (€)	Dec. 31, 2012 Probiotica USD ($)	Dec. 31, 2012 Probiotica BRL	Feb. 01, 2012 Probiotica USD ($)	Feb. 01, 2012 Probiotica BRL	Dec. 31, 2012 Probiotica Minimum	Dec. 31, 2012 Probiotica Maximum
Business Combinations
Upfront payment				$ 289,300,000																																							$ 50,000,000	$ 62,500,000	$ 65,000,000		$ 65,500,000	847,300,000	$ 164,000,000	€ 125,000,000
Payment of assumed debt				37,900,000
Potential future milestone payments				114,000,000																																						20,000,000			40,000,000		8,900,000	114,700,000	19,700,000	15,000,000
Fair value of contingent consideration				99,200,000														44,200,000																								7,900,000			1,500,000		7,600,000		16,800,000
Period of exclusive supply agreement																																																	10 years	10 years
Percentage of sales relating to the acquired assets																																																	90.00%	90.00%
Assets acquired and liabilities assumed
Cash and cash equivalents							14,119,000		14,119,000										7,255,000	(258,000)	6,997,000
Accounts receivable							10,348,000		10,348,000										29,846,000	(17,000)	29,829,000
Assets held for sale																			15,566,000		15,566,000
Inventories							3,222,000	(685,000)	2,537,000										64,819,000	(5,970,000)	58,849,000
Other current assets							4,063,000	22,000	4,085,000										2,524,000		2,524,000
Property, plant and equipment							8,181,000		8,181,000										9,027,000		9,027,000
Identifiable intangible assets, excluding IPR&D							466,408,000	(64,095,000)	402,313,000		446,958,000	(62,450,000)	384,508,000		19,450,000	(1,645,000)	17,805,000		666,619,000	764,000	667,383,000		456,720,000	(2,088,000)	454,632,000		31,934,000	3,725,000	35,659,000		109,274,000	(873,000)	108,401,000		36,277,000	36,277,000		32,414,000	32,414,000
Acquired IPR&D	546,876,000	531,304,000					15,464,000	13,151,000	28,615,000										1,234,000		1,234,000
Indemnification assets																			27,901,000		27,901,000
Other non-current assets							1,862,000		1,862,000										21,000		21,000
Current liabilities							(9,675,000)	(395,000)	(10,070,000)										(32,146,000)	(350,000)	(32,496,000)
Long-term debt, including current portion							(37,868,000)		(37,868,000)										(920,000)		(920,000)
Liability for uncertain tax position																			(6,682,000)	6,682,000
Other non-current liabilities							(158,000)		(158,000)										(28,523,000)		(28,523,000)
Deferred income taxes, net							(173,907,000)	18,386,000	(155,521,000)										(10,933,000)	373,000	(10,560,000)
Total identifiable net assets							302,059,000	(33,616,000)	268,443,000										745,608,000	1,224,000	746,832,000
Goodwill							86,802,000	33,255,000	120,057,000										70,600,000	(8,271,000)	62,329,000
Total fair value of consideration transferred							388,861,000	(361,000)	388,500,000									809,200,000	816,208,000	(7,047,000)	809,161,000																			41,900,000	107,300,000												90,500,000	158,000,000
Fair value of trade accounts receivable acquired				10,300,000														29,800,000
Gross contractual amount of trade accounts receivable acquired				10,300,000														31,100,000
Expected uncollectible of trade accounts receivable acquired																		1,300,000
Estimated weighted-average useful life						12 years				12 years				15 years				10 years				10 years				12 years				10 years				9 years			5 years
Time restriction of contractual arrangement dependent on nature of claim																																																							2 years	5 years
Acquisition-related costs	78,604,000	32,964,000	38,262,000			3,500,000												9,400,000
Revenues of acquiree since acquisition date					53,900,000													178,800,000
Net loss of acquiree since acquisition date, net of tax					(3,700,000)													(14,300,000)
Acquisition-related contingent consideration	(5,266,000)	(10,986,000)
Other disclosures
Amounts classified as Restricted																																														8,200,000
Purchase price has been placed in escrow in accordance with the indemnification provisions																																																			$ 12,900,000	22,500,000
Percentage of purchase price that has been placed in escrow in accordance with the indemnification provisions																																																			50.00%	50.00%
Period of escrow account																																																			2 years	2 years